Pieris Pharmaceuticals, Inc. (PIRS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 11:01AM EDT. Market open.
| Previous close | 11.71 |
| Open | 11.84 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 11.80 - 11.84 |
| 52-week range | 10.88 - 80.80 |
| Volume | |
| Avg. volume | 11,640 |
| Market cap | 14.587M |
| Beta (5Y monthly) | 0.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -21.60 |
| Earnings date | 08 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Investors Don't See Light At End Of Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Tunnel And Push Stock Down 27%
To the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. ( NASDAQ:PIRS ) shares are down a considerable 27...
- Simply Wall St.
Will Pieris Pharmaceuticals (NASDAQ:PIRS) Spend Its Cash Wisely?
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
ZacksPieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's Why
Pieris Pharmaceuticals (PIRS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2024 Yahoo. All rights reserved.